Current treatment options in mRCC

Discussion: Additional treatment options impact first-line treatment of mRCC

The evolving treatment landscape for HER2-positive metastatic breast cancer

Navigating current treatment options for HER2-positive MBC: Patient journey 1

Overview of skin cancer treatments, past, present and future

Advances in CLL: Expert panel Discussion

Emerging treatments in CLL: Expert Discussion

Hot topic: B-cell depletion in adult chronic ITP

Treatment options in adult chronic idiopathic thrombocytopenic purpura: Introduction

Global prostate cancer disparities and the parts both genetic and behavioural factors play

New players and targets in tumour vasculature

ecancermedicalscience editor's choice for July and August 2014